newsfilter
← Latest News
ClinicalTrials.gov·

Study of SRF114 in Patients With Advanced Solid Tumors - NCT05635643

[Part A] Rate of Dose Limiting Toxicity (DLT), [Part B] Confirmed objective response rate (ORR), [Part A, Part B] Summary of adverse events (AEs) based on treatment emergent AEs (TEAEs), (and 6 more...)